Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis.

Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Troy K, Schiano T, Mascarenhas J.

Blood Adv. 2020 Feb 25;4(4):655-666. doi: 10.1182/bloodadvances.2019001310.

PMID:
32078681
2.

Novel Therapies in Polycythemia Vera.

Tremblay D, Mascarenhas J.

Curr Hematol Malig Rep. 2020 Feb 7. doi: 10.1007/s11899-020-00564-7. [Epub ahead of print] Review.

PMID:
32034662
3.

Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation.

Naymagon L, Tremblay D, Zubizarreta N, Moshier E, Schiano T, Mascarenhas J.

J Thromb Thrombolysis. 2020 Feb 7. doi: 10.1007/s11239-020-02052-4. [Epub ahead of print]

PMID:
32034618
4.

Interferon-α: alternative first- or second-line therapeutic option for polycythaemia vera.

Mascarenhas J.

Lancet Haematol. 2020 Jan 31. pii: S2352-3026(19)30252-2. doi: 10.1016/S2352-3026(19)30252-2. [Epub ahead of print] No abstract available.

PMID:
32014126
5.

Reevaluating the role of ferritin in the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.

Naymagon L, Tremblay D, Mascarenhas J.

Eur J Haematol. 2020 Jan 28. doi: 10.1111/ejh.13391. [Epub ahead of print]

PMID:
31991015
6.

Characterization of rotavirus possessing a DS-1-like VP3 gene from pigs in Brazil: Evidence for zooanthroponotic transmission.

Neves MAO, Sousa Júnior AS, de Camargo DS, Lobo PS, Bandeira RS, Soares LS, Mascarenhas JDP.

Infect Genet Evol. 2020 Apr;79:104151. doi: 10.1016/j.meegid.2019.104151. Epub 2019 Dec 20.

PMID:
31870971
7.

A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post--polycythemia vera/essential thrombocythemia myelofibrosis (post--PV/ET MF).

Mascarenhas J, Marcellino BK, Lu M, Kremyanskaya M, Fabris F, Sandy L, Mehrotra M, Houldsworth J, Najfeld V, El Jamal S, Petersen B, Moshier E, Hoffman R.

Leuk Res. 2020 Jan;88:106272. doi: 10.1016/j.leukres.2019.106272. Epub 2019 Nov 16.

PMID:
31778911
8.

Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms.

Sapre M, Tremblay D, Wilck E, James A, Leiter A, Coltoff A, Koshy AG, Kremyanskaya M, Hoffman R, Mascarenhas JO, Gallagher EJ.

Sci Rep. 2019 Nov 12;9(1):16609. doi: 10.1038/s41598-019-53056-x.

9.

Risk factors for infections and secondary malignancies in patients with a myeloproliferative neoplasm treated with ruxolitinib: a dual-center, propensity score-matched analysis.

Tremblay D, King A, Li L, Moshier E, Coltoff A, Koshy A, Kremyanskaya M, Hoffman R, Mauro MJ, Rampal RK, Mascarenhas J.

Leuk Lymphoma. 2020 Mar;61(3):660-667. doi: 10.1080/10428194.2019.1688323. Epub 2019 Nov 12.

PMID:
31711337
10.

JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemia.

Venugopal S, Bar-Natan M, Mascarenhas JO.

Blood Rev. 2019 Oct 25:100634. doi: 10.1016/j.blre.2019.100634. [Epub ahead of print] Review.

PMID:
31677846
11.

Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera.

Ronner L, Mascarenhas J, Moshier EL.

Blood Adv. 2019 Oct 22;3(20):3010-3012. doi: 10.1182/bloodadvances.2019000822. No abstract available.

12.

Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience.

Tremblay D, Vogel AS, Moshier E, Hoffman R, Kremyanskaya M, Zhou S, Schiano T, Mascarenhas J.

Eur J Haematol. 2020 Jan;104(1):72-73. doi: 10.1111/ejh.13335. Epub 2019 Oct 16. No abstract available.

PMID:
31587352
13.

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.

Yacoub A, Mascarenhas J, Kosiorek H, Prchal JT, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Papaemmanuil E, Salama M, Singer-Weinberg R, Rampal R, Goldberg JD, Barbui T, Mesa R, Dueck AC, Hoffman R.

Blood. 2019 Oct 31;134(18):1498-1509. doi: 10.1182/blood.2019000428.

14.

The role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes.

Naymagon L, Tremblay D, Schiano T, Mascarenhas J.

J Thromb Thrombolysis. 2020 Feb;49(2):325-331. doi: 10.1007/s11239-019-01949-z.

PMID:
31493290
15.

SLAM dunk for myelofibrosis?

Marcellino BK, Mascarenhas J.

Blood. 2019 Sep 5;134(10):789-791. doi: 10.1182/blood.2019002119. No abstract available.

PMID:
31488456
16.

Management of advanced phase myeloproliferative neoplasms.

Marcellino B, Mascarenhas J.

Clin Adv Hematol Oncol. 2019 Jul;17(7):405-411.

PMID:
31449507
17.

Prevalence of rotavirus and human bocavirus in immunosuppressed individuals after renal transplantation in the Northern Region of Brazil.

Castro LRP, Calvet FC, Sousa KL, Silva VP, Lobo PS, Penha ET Junior, Guerra SFS, Bezerra DAM, Mascarenhas JDP, Pinheiro HHC, Costa IB, Resque HR, Soares LS.

J Med Virol. 2019 Dec;91(12):2125-2133. doi: 10.1002/jmv.25569. Epub 2019 Aug 29.

PMID:
31429939
18.

Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

Yeoh CB, Van Rooyen C, Tan KS, Mascarenhas J, Yang G, Kerpelev M, Tollinche LE.

EC anaesth. 2019 Aug;5(8):233-238. Epub 2019 Jul 12.

19.

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.

Mascarenhas J, Kosiorek H, Prchal J, Yacoub A, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Salama ME, Weinberg RS, Rampal R, Goldberg JD, Mesa R, Dueck AC, Hoffman R.

Leukemia. 2019 Dec;33(12):2974-2978. doi: 10.1038/s41375-019-0524-7. Epub 2019 Jul 30. No abstract available.

20.

Reconstitution and Coupling of DNA Replication and Segregation in a Biomimetic System.

Hürtgen D, Mascarenhas J, Heymann M, Murray SM, Schwille P, Sourjik V.

Chembiochem. 2019 Oct 15;20(20):2633-2642. doi: 10.1002/cbic.201900299. Epub 2019 Aug 28.

21.

Blastic Plasmacytoid Dendritic Cell Neoplasm-Current Insights.

Venugopal S, Zhou S, El Jamal SM, Lane AA, Mascarenhas J.

Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):545-554. doi: 10.1016/j.clml.2019.06.002. Epub 2019 Jun 13. Review.

PMID:
31281107
22.

Immune Checkpoint Blockade Enhances Shared Neoantigen-Induced T-cell Immunity Directed against Mutated Calreticulin in Myeloproliferative Neoplasms.

Cimen Bozkus C, Roudko V, Finnigan JP, Mascarenhas J, Hoffman R, Iancu-Rubin C, Bhardwaj N.

Cancer Discov. 2019 Sep;9(9):1192-1207. doi: 10.1158/2159-8290.CD-18-1356. Epub 2019 Jul 2.

PMID:
31266769
23.

Molecular epidemiology of human bocavirus in children with acute gastroenteritis from North Region of Brazil.

Soares LS, Lima ABF, Pantoja KC, Lobo PS, Cruz JF, Guerra SFS, Bezerra DAM, Bandeira RS, Mascarenhas JDP.

J Med Microbiol. 2019 Aug;68(8):1233-1239. doi: 10.1099/jmm.0.001026. Epub 2019 Jun 19.

PMID:
31215861
24.

Myoclonic jerks complicating treatment of acute promyelocytic leukemia: case report and literature review.

Rhee JY, Tremblay D, Chan AM, Tallman MS, Mascarenhas J.

Blood Adv. 2019 Jun 25;3(12):1854-1857. doi: 10.1182/bloodadvances.2019000249. No abstract available.

25.

Rotavirus antigenemia as a common event among children hospitalised for severe, acute gastroenteritis in Belém, northern Brazil.

Justino MCA, Campos EA, Mascarenhas JDP, Soares LS, Guerra SFS, Furlaneto IP, Pavão MJC Jr, Maciel TS, Farias FP, Bezerra OM, Vinente CBG, Barros RJS, Linhares AC.

BMC Pediatr. 2019 Jun 12;19(1):193. doi: 10.1186/s12887-019-1535-2.

26.

Refractory gout in primary myelofibrosis.

Venugopal S, Mascarenhas J.

Blood. 2019 Jun 6;133(23):2550. doi: 10.1182/blood.2019000537. No abstract available.

PMID:
31171541
27.

Oral idasanutlin in patients with polycythemia vera.

Mascarenhas J, Lu M, Kosiorek H, Virtgaym E, Xia L, Sandy L, Mesa R, Petersen B, Farnoud N, Najfeld V, Rampal R, Dueck A, Hoffman R.

Blood. 2019 Aug 8;134(6):525-533. doi: 10.1182/blood.2018893545. Epub 2019 Jun 5.

28.

Emergence of G12P[6] rotavirus strains among hospitalised children with acute gastroenteritis in Belém, Northern Brazil, following introduction of a rotavirus vaccine.

Guerra SFS, Fecury PCMS, Bezerra DAM, Lobo PS, Penha Júnior ET, Sousa Júnior EC, Mascarenhas JDP, Soares LS, Justino MCA, Linhares AC.

Arch Virol. 2019 Aug;164(8):2107-2117. doi: 10.1007/s00705-019-04295-w. Epub 2019 May 29.

PMID:
31144039
29.

The World Health Organization trauma checklist versus Trauma Team Time-out: A perspective.

Fitzgerald M, Reilly S, Smit V, Kim Y, Mathew J, Boo E, Alqahtani A, Chowdhury S, Darez A, Mascarenhas JB, O'Keeffe F, Noonan M, Nickson C, Marquez M, Li WA, Zhang YL, Williams K, Mitra B.

Emerg Med Australas. 2019 Oct;31(5):882-885. doi: 10.1111/1742-6723.13306. Epub 2019 May 13.

30.

A Novel t(1;9)(p36;p24.1) JAK2 Translocation and Review of the Literature.

Levavi H, Tripodi J, Marcellino B, Mascarenhas J, Jones AV, Cross NCP, Gruenstein D, Najfeld V.

Acta Haematol. 2019;142(2):105-112. doi: 10.1159/000498945. Epub 2019 May 7. Review.

31.

Relevant updates in systemic mastocytosis.

Coltoff A, Mascarenhas J.

Leuk Res. 2019 Jun;81:10-18. doi: 10.1016/j.leukres.2019.04.001. Epub 2019 Apr 4. Review.

PMID:
30978435
32.

Eosinophilia in acute myeloid leukemia: Overlooked and underexamined.

Naymagon L, Marcellino B, Mascarenhas J.

Blood Rev. 2019 Jul;36:23-31. doi: 10.1016/j.blre.2019.03.007. Epub 2019 Mar 30. Review.

PMID:
30948162
33.

Visual Impairment in Fungal Versus Bacterial Corneal Ulcers 4 Years After Successful Antimicrobial Treatment.

Prajna NV, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R, McClintic SM, O'Brien KS, Ray KJ, Acharya NR, Lietman TM, Keenan JD.

Am J Ophthalmol. 2019 Aug;204:124-129. doi: 10.1016/j.ajo.2019.03.010. Epub 2019 Mar 20.

PMID:
30902692
34.

First Complete Genome Sequence of a Feline Alphacoronavirus 1 Strain from Brazil.

de Barros BCV, de Castro CMO, Pereira D, Ribeiro LG, Júnior JWBD, Casseb SMM, Holanda GM, Cruz ACR, Júnior ECS, Mascarenhas JDP.

Microbiol Resour Announc. 2019 Mar 7;8(10). pii: e01535-18. doi: 10.1128/MRA.01535-18. eCollection 2019 Mar.

35.

Predictors of early hemorrhage in acute promyelocytic leukemia.

Naymagon L, Moshier E, Tremblay D, Mascarenhas J.

Leuk Lymphoma. 2019 Oct;60(10):2394-2403. doi: 10.1080/10428194.2019.1581187. Epub 2019 Mar 8.

PMID:
30849255
36.

G1P[8] Rotavirus in children with severe diarrhea in the post-vaccine introduction era in Brazil: Evidence of reassortments and structural modifications of the antigenic VP7 and VP4 regions.

Santos FS, Sousa Junior EC, Guerra SFS, Lobo PS, Penha Junior ET, Lima ABF, Vinente CBG, Chagas EHN, Justino MCA, Linhares AC, Matthijnssens J, Soares LS, Mascarenhas JDP.

Infect Genet Evol. 2019 Apr;69:255-266. doi: 10.1016/j.meegid.2019.02.009. Epub 2019 Feb 11.

PMID:
30763774
37.

The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib.

Tremblay D, Putra J, Vogel A, Winters A, Hoffman R, Schiano TD, Fiel MI, Mascarenhas JO.

Case Rep Hematol. 2019 Jan 6;2019:3294046. doi: 10.1155/2019/3294046. eCollection 2019.

38.

Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.

Kamath GR, Tremblay D, Coltoff A, Caro J, Lancman G, Bhalla S, Najfeld V, Mascarenhas J, Taioli E.

Carcinogenesis. 2019 Jul 4;40(5):651-660. doi: 10.1093/carcin/bgz014.

PMID:
30715157
39.

Correction: Rotavirus A in wild and domestic animals from areas with environmental degradation in the Brazilian Amazon.

Barros BCV, Chagas EN, Bezerra LW, Ribeiro LG, Duarte Júnior JWB, Pereira D, Penha Junior ETD, Silva JR, Bezerra DAM, Bandeira RS, Pinheiro HHC, Guerra SFDS, Guimarães RJPSE, Mascarenhas JDP.

PLoS One. 2019 Jan 23;14(1):e0211311. doi: 10.1371/journal.pone.0211311. eCollection 2019.

40.

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.

Mascarenhas J, Baer MR, Kessler C, Hexner E, Tremblay D, Price L, Sandy L, Weinberg R, Pahl H, Silverman LR, Goldberg JD, Kosiorek H, Dueck AC, Hoffman R.

Leuk Lymphoma. 2019 May;60(5):1343-1345. doi: 10.1080/10428194.2018.1532509. Epub 2019 Jan 22. No abstract available.

PMID:
30668266
41.

Proposed New Strain of Canine Kobuvirus from Fecal Samples of Brazilian Domestic Dogs.

Barros BCV, Castro CMO, Pereira D, Ribeiro LG, Júnior JWBD, Casseb SMM, Holanda GM, Cruz ACR, Júnior ECS, Mascarenhas JDP.

Microbiol Resour Announc. 2019 Jan 3;8(1). pii: e01292-18. doi: 10.1128/MRA.01292-18. eCollection 2019 Jan.

42.

Automated notifications improve time to anesthesia induction: Integrating health information technology systems to enhance perioperative efficiency.

Yeoh C, Mascarenhas J, Tan KS, Tollinche L.

Anaesth Anaesth. 2018 Dec;2(2). doi: 10.15761/JAA.1000116. Epub 2018 Oct 3.

43.

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis.

Tamari R, Rapaport F, Zhang N, McNamara C, Kuykendall A, Sallman DA, Komrokji R, Arruda A, Najfeld V, Sandy L, Medina J, Litvin R, Famulare CA, Patel MA, Maloy M, Castro-Malaspina H, Giralt SA, Weinberg RS, Mascarenhas JO, Mesa R, Rondelli D, Dueck AC, Levine RL, Gupta V, Hoffman R, Rampal RK.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1142-1151. doi: 10.1016/j.bbmt.2019.01.002. Epub 2019 Jan 6.

PMID:
30625392
44.

Differences in the clinical and genetic profile of Hispanic and non-Hispanic acute myeloid leukemia patients.

Kamath GR, Tremblay D, Coltoff A, Caro J, Lancman G, Bhalla S, Najfeld V, Mascarenhas J, Taioli E.

Leuk Res. 2019 Feb;77:1-4. doi: 10.1016/j.leukres.2018.12.006. Epub 2018 Dec 19. No abstract available.

PMID:
30594101
45.

Chronic Neutrophilic Leukemia: Current and Future Perspectives.

Venugopal S, Mascarenhas J.

Clin Lymphoma Myeloma Leuk. 2019 Mar;19(3):129-134. doi: 10.1016/j.clml.2018.11.012. Epub 2018 Nov 29. Review.

PMID:
30581159
46.

Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53.

Marcellino BK, Hoffman R, Tripodi J, Lu M, Kosiorek H, Mascarenhas J, Rampal RK, Dueck A, Najfeld V.

Blood Adv. 2018 Dec 26;2(24):3581-3589. doi: 10.1182/bloodadvances.2018024018.

47.

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.

Rampal RK, Mascarenhas JO, Kosiorek HE, Price L, Berenzon D, Hexner E, Abboud CN, Kremyanskaya M, Weinberg RS, Salama ME, Menghrajani K, Najfeld V, Sandy L, Heaney ML, Levine RL, Mesa RA, Dueck AC, Goldberg JD, Hoffman R.

Blood Adv. 2018 Dec 26;2(24):3572-3580. doi: 10.1182/bloodadvances.2018019661.

48.

Rotavirus A in wild and domestic animals from areas with environmental degradation in the Brazilian Amazon.

de Barros BCV, Chagas EN, Bezerra LW, Ribeiro LG, Duarte Júnior JWB, Pereira D, da Penha Junior ET, Silva JR, Bezerra DAM, Bandeira RS, Pinheiro HHC, Guerra SFDS, Guimarães RJPSE, Mascarenhas JDP.

PLoS One. 2018 Dec 18;13(12):e0209005. doi: 10.1371/journal.pone.0209005. eCollection 2018. Erratum in: PLoS One. 2019 Jan 23;14(1):e0211311.

49.

Rotavirus analyses by SYBR Green real-time PCR and microbiological contamination in bivalves cultivated in coastal water of Amazonian Brazil.

Marinho ANR, Rocha DCC, Kanai YK, Alves CM, Costa DC, Sousa AH, Barros BCV, Bonfim MCMS, Mascarenhas JDP.

J Water Health. 2018 Dec;16(6):970-979. doi: 10.2166/wh.2018.130.

PMID:
30540271
50.

Does hydroxycarbamide therapy really induce leukemic transformation in patients with essential thrombocythemia?

Marcellino B, Hoffman R, Mascarenhas J.

Leuk Res. 2019 Jan;76:94-95. doi: 10.1016/j.leukres.2018.11.011. Epub 2018 Nov 22. No abstract available.

PMID:
30501902

Supplemental Content

Loading ...
Support Center